NCT02575638View on ClinicalTrials.gov

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

PHASE1UnknownINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 1, 2019

Study Completion Date

February 1, 2020

Conditions
Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
Interventions
DRUG

CZ48

CZ48 is an analog of the topoisomerase I inhibitor Camptothecin (CPT). CPT is a natural extract from the tree Camptotheca acuminata

Trial Locations (1)

78229

RECRUITING

University of Texas Health Science Center, San Antonio

Sponsors
All Listed Sponsors
collaborator

The University of Texas Health Science Center at San Antonio

OTHER

lead

Cao Pharmaceuticals Inc.

INDUSTRY